Download full-text PDF

Source
http://dx.doi.org/10.1016/j.antiviral.2019.104559DOI Listing

Publication Analysis

Top Keywords

nvn1000 novel
4
novel nitric
4
nitric oxide-releasing
4
oxide-releasing compound
4
compound inhibits
4
inhibits hpv-18
4
hpv-18 virus
4
virus production
4
production interfering
4
interfering oncoprotein
4

Similar Publications

Article Synopsis
  • Molluscum contagiosum (MC) is a common skin infection in children caused by the highly contagious molluscum contagiosum poxvirus (MCV), with limited treatment options available.
  • Researchers are investigating berdazimer sodium, a new topical treatment, to assess its antiviral properties against poxviruses using vaccinia virus as a model since MCV can't be studied directly in the lab.
  • The study shows that berdazimer sodium not only reduces virus replication but also interferes with early gene expression in MCV-infected cells, offering a possible explanation for its effectiveness in treating MC.
View Article and Find Full Text PDF
Article Synopsis
  • Tinea pedis, or athlete's foot, is a common fungal skin infection treated topically, with SB208 being a new treatment that releases nitric oxide to combat the infection.
  • A phase 2 trial showed that patients treated with SB208 had a higher rate of negative fungal cultures after 14 days compared to those using a placebo, particularly with the 4% dose.
  • At 42 days, SB208 also demonstrated greater mycological and clinical cures, and it was generally safe with no serious side effects reported.
View Article and Find Full Text PDF

Cutaneous and superficial fungal infections affecting the skin, nails, and hair of humans are caused primarily by dermatophytes of the genera and or by yeasts of the genera and Onychomycosis is a common fungal infection of the nail that frequently coexists with tinea pedis, the most prevalent mycotic skin infection. Efficacy rates for current topical onychomycosis therapies are hampered by low drug penetration across the nail plate, which is theoretically obviated with nitric oxide (NO)-based topical therapies. The Nitricil technology platform is comprised of polysiloxane-based macromolecules that stably release therapeutic levels of NO.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!